BIOGEN IDEC INC 4
4 · BIOGEN IDEC INC · Filed Oct 4, 2005
Insider Transaction Report
Form 4
BIOGEN IDEC INCBIIB
KELLER THOMAS F
Director
Transactions
- Exercise/Conversion
Common Stock
2005-10-01$15.16/sh+10,350$156,906→ 27,600 total(indirect: Keller Bros. Investment LLP) - Sale
Common Stock
2005-10-01$39.28/sh−400$15,712→ 22,550 total(indirect: Keller Bros. Investment LLP) - Sale
Common Stock
2005-10-01$39.56/sh−100$3,956→ 27,500 total(indirect: Keller Bros. Investment LLP) - Sale
Common Stock
2005-10-01$39.32/sh−900$35,388→ 24,050 total(indirect: Keller Bros. Investment LLP) - Sale
Common Stock
2005-10-01$39.43/sh−500$19,715→ 26,400 total(indirect: Keller Bros. Investment LLP) - Sale
Common Stock
2005-10-01$39.38/sh−300$11,814→ 25,400 total(indirect: Keller Bros. Investment LLP) - Sale
Common Stock
2005-10-01$39.33/sh−150$5,899→ 24,950 total(indirect: Keller Bros. Investment LLP) - Sale
Common Stock
2005-10-01$39.45/sh−200$7,890→ 26,900 total(indirect: Keller Bros. Investment LLP) - Exercise/Conversion
Stock Option (right-to-buy)
2005-10-01−10,350→ 17,250 total(indirect: Keller Bros. Investment LLP)Exercise: $15.16Exp: 2006-09-20→ Common Stock (10,350 underlying)
Holdings
- 920(indirect: Keller Bros. Investment LLP)
Common Stock
Footnotes (5)
- [F1]Options are held by a limited partnership of which the reporting person is a general partner.
- [F2]Sale pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934.
- [F3]Common stock held by a limited partnership of which the reporting person is a general partner.
- [F4]Granted under one of the Issuer's stock option plans, in an exempt transaction under SEC rule 16(b)-3(d).
- [F5]The stock option became exerciseable in three (3) equal installments, commencing one year after the grant date of 09/20/96.